ArticleDrug delivery and translational research2025

Delivery of exogenous miR-19b by Wharton's Jelly Mesenchymal Stem Cells attenuates transplanted kidney ischemia/reperfusion injury by regulating cellular metabolism.

Xiaoqiang Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.